IQ EQ FUND MANAGEMENT IRELAND Ltd Has $927,000 Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

IQ EQ FUND MANAGEMENT IRELAND Ltd trimmed its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,402 shares of the company’s stock after selling 639 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Henry Schein were worth $927,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Pathstone Holdings LLC lifted its holdings in shares of Henry Schein by 3.1% in the third quarter. Pathstone Holdings LLC now owns 24,028 shares of the company’s stock valued at $1,752,000 after purchasing an additional 732 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Henry Schein by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock valued at $85,662,000 after acquiring an additional 6,184 shares in the last quarter. Cerity Partners LLC boosted its position in Henry Schein by 12.3% during the 3rd quarter. Cerity Partners LLC now owns 26,339 shares of the company’s stock worth $1,920,000 after acquiring an additional 2,894 shares during the last quarter. Daiwa Securities Group Inc. grew its stake in shares of Henry Schein by 11.4% during the 3rd quarter. Daiwa Securities Group Inc. now owns 15,636 shares of the company’s stock worth $1,140,000 after acquiring an additional 1,596 shares in the last quarter. Finally, Bank of Montreal Can raised its holdings in shares of Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after purchasing an additional 558,689 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on HSIC shares. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Finally, Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Shares of HSIC stock opened at $69.40 on Friday. The company has a market capitalization of $8.62 billion, a price-to-earnings ratio of 28.56, a PEG ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a 50-day simple moving average of $74.71 and a 200 day simple moving average of $72.60.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.66 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.